Page last updated: 2024-11-03

ro 15-4513 and Epilepsy

ro 15-4513 has been researched along with Epilepsy in 1 studies

Ro 15-4513: a partial inverse agonist of benzodiazepine receptors

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, ZJ1
Postma, T1
Obeng, K1
Russell, S1
Weiss, SR1
Post, RM1

Other Studies

1 other study available for ro 15-4513 and Epilepsy

ArticleYear
The benzodiazepine partial inverse agonist Ro15-4513 alters anticonvulsant and lethal effects of carbamazepine in amygdala-kindled rats.
    Neuroscience letters, 2002, Sep-06, Volume: 329, Issue:3

    Topics: Affinity Labels; Amygdala; Animals; Anticonvulsants; Azides; Benzodiazepines; Carbamazepine; Drug In

2002